Why is Shukra Pharma. falling/rising?

As of 17-Jul, Shukra Pharmaceuticals Ltd is experiencing a price increase, currently at 22.01, reflecting a change of 0.43 or 1.99% upward. The stock has shown remarkable performance, gaining 64.25% over the last 15 days and outperforming its sector by 1.57% today. Over various periods, the stock has delivered impressive returns, including a 150.97% increase over the past year and a staggering 2459.52% over the last three years. Additionally, the company maintains a strong ability to service its debt, evidenced by a low Debt to EBITDA ratio of 1.28 times, and has demonstrated healthy long-term growth with an annual operating profit increase of 60.53%.
In the broader market context, Shukra Pharmaceuticals has significantly outperformed the Sensex, which has seen a decline of 1.12% over the past week while Shukra's stock rose by 10.27%. This stark contrast highlights the stock's strong market position and investor confidence, despite a recent decline in delivery volume, which fell by 63.34% against the 5-day average. Overall, the stock's consistent upward trajectory and robust financial health contribute to its rising price, setting it apart from the broader market trends.